BRG Quarterly Healthcare M&A Update | Q3 2023

Overall health services deal volume is down from the high volumes seen in 2021 and 2022, largely attributed to difficult financial conditions and disparate views on valuations. The prior two years of near-record-breaking deal volume have been replaced with stalled activity fueled by uncertainty in the market, currently defined by high interest rates, global unrest, and economic unknowns. Despite the difficult market conditions, activity for year-to-date healthcare services deals remains resilient, but deal volume in the fourth quarter may reflect buyers’ continued concerns with projected performance, cost of capital, and valuation expectations.

Read the full article: BRG Quarterly Healthcare M&A Update | Q3 2023 //


Leave a Comment

Your email address will not be published.

Scroll to Top